Healthcare provider profile · identity verified

Tim Arthur Beidelschies, MD

Family Practice · FOSTORIA, OH · NPI 1487714606

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	529	131
Levothyroxine Sodium	Levothyroxine Sodium	391	80
Hydrochlorothiazide	Hydrochlorothiazide	347	73
Furosemide	Furosemide	344	50
Amlodipine Besylate	Amlodipine Besylate	333	81
Lisinopril	Lisinopril	331	83
Pantoprazole Sodium	Pantoprazole Sodium	328	70
Metformin Hcl	Metformin Hcl	299	68
Potassium Chloride	Potassium Chloride	278	43
Simvastatin	Simvastatin	264	62
Losartan Potassium	Losartan Potassium	254	58
Omeprazole	Omeprazole	250	58
Metoprolol Succinate	Metoprolol Succinate	218	54
Gabapentin	Gabapentin	206	45
Tramadol Hcl	Tramadol Hcl	202	31
Sertraline Hcl	Sertraline Hcl	196	47
Rosuvastatin Calcium	Rosuvastatin Calcium	191	44
Warfarin Sodium	Warfarin Sodium	183	16
Lorazepam	Lorazepam	176	33
Citalopram Hbr	Citalopram Hydrobromide	158	32
Meloxicam	Meloxicam	154	49
Montelukast Sodium	Montelukast Sodium	150	39
Metoprolol Tartrate	Metoprolol Tartrate	147	33
Eliquis	Apixaban	146	25
Glimepiride	Glimepiride	137	31
Allopurinol	Allopurinol	132	26
Prednisone	Prednisone	129	85
Buspirone Hcl	Buspirone Hcl	125	20
Carvedilol	Carvedilol	119	25
Alprazolam	Alprazolam	111	14
Acetaminophen-Codeine	Acetaminophen With Codeine	106	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	29
Alendronate Sodium	Alendronate Sodium	103	19
Cephalexin	Cephalexin	103	63
Pioglitazone Hcl	Pioglitazone Hcl	97	22
Spironolactone	Spironolactone	96	17
Albuterol Sulfate Hfa	Albuterol Sulfate	94	26
Tamsulosin Hcl	Tamsulosin Hcl	94	19
Clopidogrel	Clopidogrel Bisulfate	92	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	91	16
Januvia	Sitagliptin Phosphate	89	14
Tizanidine Hcl	Tizanidine Hcl	88	28
Atenolol	Atenolol	86	14
Famotidine	Famotidine	86	12
Zolpidem Tartrate	Zolpidem Tartrate	85	21
Fluoxetine Hcl	Fluoxetine Hcl	84	19
Synthroid	Levothyroxine Sodium	76	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	14
Diazepam	Diazepam	73	11
Escitalopram Oxalate	Escitalopram Oxalate	67	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	65	53
Clonazepam	Clonazepam	63	suppressed
Donepezil Hcl	Donepezil Hcl	63	suppressed
Clonidine Hcl	Clonidine Hcl	62	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	60	30
Duloxetine Hcl	Duloxetine Hcl	59	12
Mirtazapine	Mirtazapine	56	13
Azithromycin	Azithromycin	53	45
Pregabalin	Pregabalin	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	19
Jardiance	Empagliflozin	48	suppressed
Lovastatin	Lovastatin	47	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	29
Ezetimibe	Ezetimibe	46	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	20
Bupropion Xl	Bupropion Hcl	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Baclofen	Baclofen	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Ibuprofen	Ibuprofen	35	12
Naproxen	Naproxen	35	suppressed
Trazodone Hcl	Trazodone Hcl	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Bumetanide	Bumetanide	33	suppressed
Finasteride	Finasteride	32	11
Fluconazole	Fluconazole	32	19
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	12
Levetiracetam	Levetiracetam	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Clotrimazole	Clotrimazole	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	24
Glipizide	Glipizide	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Ondansetron Odt	Ondansetron	24	19
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Verapamil Er Pm	Verapamil Hcl	23	suppressed
Primidone	Primidone	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Dilt-Xr	Diltiazem Hcl	21	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Loperamide	Loperamide Hcl	20	suppressed
Clonidine	Clonidine	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Fosinopril Sodium	Fosinopril Sodium	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Levofloxacin	Levofloxacin	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Methylprednisolone	Methylprednisolone	15	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Nystatin	Nystatin	14	11
Oxaprozin	Oxaprozin	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levocarnitine	Levocarnitine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error